BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14965568)

  • 21. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
    Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
    Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local impact of the English arm of the UK Bowel Cancer Screening Pilot study.
    Goodyear SJ; Stallard N; Gaunt A; Parker R; Williams N; Wong L
    Br J Surg; 2008 Sep; 95(9):1172-9. PubMed ID: 18690636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A decision tool for predicting sentinel node accuracy from breast tumor size and grade.
    Coombs N; Chen W; Taylor R; Boyages J
    Breast J; 2007; 13(6):593-8. PubMed ID: 17983402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive lobular breast cancer. Prognostic significance of histological malignancy grading.
    Talman ML; Jensen MB; Rank F
    Acta Oncol; 2007; 46(6):803-9. PubMed ID: 17653904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surgical aspects of breast cancer screening at our hospital].
    Márkus B; Bajner A; Csejtei A; Firisz B; Hegedus A; Kocsis E; Kovács B; Pintér G; Tóth C
    Magy Seb; 2006 Oct; 59(5):375-82. PubMed ID: 17201346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screen detected breast cancer in an Asian population: pathological findings of the Singapore breast screening project.
    Tan PH; Chiang GS; Ng EH; Low SC; Ng FC
    Breast; 1999 Jun; 8(3):120-5. PubMed ID: 14965727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
    Laura S; Coombs NJ; Ung O; Boyages J
    ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of invasive breast cancer detected in a screened population with invasive breast cancers detected at rapid access diagnostic facilities.
    Nisbet AP; Borthwick-Clarke A
    Breast; 1999 Jun; 8(3):133-4. PubMed ID: 14965730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Breast self-examination also valuable in women participating in a screening programme].
    Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
    Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
    Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.